Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Free Radic Biol Med ; 42(5): 686-97, 2007 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-17291992

RESUMO

In activated macrophages, the rel/NF-kappaB transcription factors are known to play important roles in interleukin-12 (IL-12) p40 regulation by nitric oxide (NO). However, the relative contributions of these factors are not well understood. Here, we describe a dominant role for c-rel involving p38 mitogen-activated protein kinase (p38 MAPK) and calmodulin (CaM) protein in NO-mediated IL-12 p40 inhibition in activated macrophages. Inhibition of NO production by aminoguanidine increased, whereas sodium nitroprusside (SNP; an exogenous NO generator) reduced, nuclear c-rel levels in LPS + IFN-gamma-activated RAW 264.7 macrophages. Overexpression of c-rel but not p65 NF-kappaB increased IL-12 p40 during NO treatment. The p38 MAPK phosphorylation is increased by NO, and inhibition of p38 MAPK in SNP-treated macrophages by SB203580 or transient expression of a dominant-negative mutant of p38 MAPK upregulated both nuclear c-rel and IL-12 p40 levels, indicating that NO targeted the p38 MAPK pathway to inhibit c-rel and IL-12 p40. Cytoplasmic CaM level was increased by NO, and SB203580 decreased the CaM level in NO-exposed macrophages. Inhibition of CaM activity by trifluoperazine rescued the inhibitory effect of NO on c-rel and IL-12 p40. Our findings indicate that c-rel plays an important role in NO-mediated inhibition of IL-12 p40 and is regulated by p38 MAPK through CaM protein.


Assuntos
Calmodulina/metabolismo , Subunidade p40 da Interleucina-12/metabolismo , Óxido Nítrico/farmacologia , Proteínas Proto-Oncogênicas c-rel/metabolismo , Proteínas Quinases p38 Ativadas por Mitógeno/fisiologia , Animais , Células Cultivadas , Guanidinas/farmacologia , Macrófagos/efeitos dos fármacos , Macrófagos/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Óxido Nítrico Sintase Tipo II/antagonistas & inibidores , Nitroprussiato/farmacologia , Proteínas Proto-Oncogênicas c-rel/fisiologia
2.
Blood ; 107(4): 1513-20, 2006 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-16249388

RESUMO

Although the antimicrobial activity of reactive oxygen species (ROSs) is well defined, the role of ROSs in regulating the immune response of the body is not well understood. We now provide evidence that hydrogen peroxide (H2O2), a major component of ROSs, inhibits interleukin-12 (IL-12) p40 and IL-12 p70 induction in murine macrophages and catalase pretreatment prevents H2O2-mediated down-regulation of IL-12. Endogenous accumulation of H2O2/ROSs in macrophages treated with alloxan resulted in IL-12 p40 inhibition. Although nuclear expression of both p50 and p65 NF-kappaB increased on H2O2 exposure, nuclear c-rel level was inhibited. Overexpression of c-rel restored IL-12 p40 on stimulation with lipopolysaccharide plus IFN-gamma during H2O2 treatment. H2O2 did not inhibit c-rel induction in cytosol; however, it prevented the transport of c-rel from cytosol to the nucleus. H2O2 activated calmodulin (CaM) protein in the cytosol, which subsequently sequestered c-rel in the cytosol preventing its transport to the nucleus. The CaM inhibitor trifIuoperazine increased both nuclear c-rel and IL-12 p40 levels in H2O2-treated macrophages, emphasizing a role of CaM in these processes. H2O2/ROSs thus down-regulate IL-12 induction in macrophages by a novel pathway inhibiting c-rel translocation to the nucleus through activation of CaM protein.


Assuntos
Calmodulina/metabolismo , Peróxido de Hidrogênio/farmacologia , Interleucina-12/biossíntese , Macrófagos/imunologia , Subunidades Proteicas/imunologia , Proteínas Proto-Oncogênicas c-rel/metabolismo , Animais , Interleucina-12/antagonistas & inibidores , Interleucina-12/imunologia , Subunidade p40 da Interleucina-12 , Macrófagos/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos BALB C , Subunidades Proteicas/biossíntese , Subunidades Proteicas/efeitos dos fármacos , Transporte Proteico/efeitos dos fármacos , Trifluoperazina/farmacologia
3.
Immunology ; 114(3): 313-21, 2005 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15720433

RESUMO

Interleukin-10 (IL-10) is known to inhibit IL-12 production in macrophages primarily at the transcriptional level with the involvement of p50 and p65 nuclear factor-kappaB (NF-kappaB). We demonstrate that the c-rel transcription factor also plays a major role in IL-10-mediated IL-12 suppression. Treatment of macrophages with recombinant IL-10 inhibited nuclear c-rel levels, whereas addition of neutralizing anti-IL-10 antibody up-regulated both nuclear c-rel levels and IL-12 production by macrophages. Decreased nuclear c-rel was associated with a reduction in phosphorylation of inhibitory kappa B alpha (IkappaBalpha) in the cytoplasm, indicating that IL-10 prevents degradation of IkappaBalpha and the subsequent translocation of c-rel into the nucleus. Treatment with leptomycin B, a known inhibitor of c-rel at a concentration of 10 nm, when used with anti-IL-10 antibody, resulted in reduced expression of IL-12. In a complementary experiment, in vitro transient expression of p65 NF-kappaB could not rescue the inhibitory effect of IL-10 on IL-12 production, suggesting that NF-kappaB alone was not sufficient to restore IL-12 production during IL-10 treatment. However, over-expression of c-rel resulted in IL-12 restoration upon stimulation with lipopolysaccharide plus interferon-gamma during IL-10 treatment. Our studies highlight the involvement of c-rel in IL-10-mediated IL-12 regulation.


Assuntos
Interleucina-10/farmacologia , Interleucina-12/biossíntese , Macrófagos/imunologia , Proteínas Proto-Oncogênicas c-rel/fisiologia , Animais , Western Blotting , Núcleo Celular/metabolismo , Células Cultivadas , Proteínas de Ligação a DNA/metabolismo , Proteínas I-kappa B/metabolismo , Interleucina-10/imunologia , Lipopolissacarídeos/imunologia , Macrófagos/efeitos dos fármacos , Camundongos , Inibidor de NF-kappaB alfa , NF-kappa B/metabolismo , Fosforilação/efeitos dos fármacos , Proteínas Proto-Oncogênicas c-rel/antagonistas & inibidores , Proteínas Recombinantes/farmacologia , Fator de Transcrição RelA , Regulação para Cima/imunologia
4.
Biotechniques ; 37(3): 418, 420, 422-3, 2004 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-15470897

RESUMO

The production of correctly folded protein in Escherichia coli is often challenging because of aggregation of the overexpressed protein into inclusion bodies. Although a number of general and protein-specific techniques are available, their effectiveness varies widely. We report a novel method for enhancing the solubility of overexpressed proteins. Presence of a dipeptide, glycylglycine, in the range of 100 mM to 1 M in the medium was found to significantly enhance the solubility (up to 170-fold) of the expressed proteins. The method has been validated using mycobacterial proteins, resulting in improved solubilization, which were otherwise difficult to express as soluble proteins in E. coli. This method can also be used to enhance the solubility of other heterologous recombinant proteins expressed in a bacterial system.


Assuntos
Proteínas de Bactérias/genética , Escherichia coli/genética , Glicilglicina , Mycobacterium tuberculosis/genética , Proteínas Recombinantes/biossíntese , Proteínas de Bactérias/biossíntese , Clonagem Molecular , Escherichia coli/metabolismo , Regulação Bacteriana da Expressão Gênica , Corpos de Inclusão , Dobramento de Proteína , Proteínas Recombinantes/química , Análise de Sequência de DNA , Solubilidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...